{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:30:02Z","timestamp":1775251802654,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,3,16]]},"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Symptomatic knee osteoarthritis (OA) is common. Advanced knee OA is successfully treated with joint replacement surgery, but effectively managing mild to moderate knee OA can be difficult. Angiogenesis increases with OA and might contribute to pain and structural damage. Modifying angiogenesis is a potential treatment pathway for OA. The aim of the current study is to determine whether transcatheter arterial embolisation of abnormal neovasculature arising from the genicular arterial branches improves knee pain, physical function and quality of life in people with mild to moderate symptomatic knee OA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The study is a single centre, parallel-arm, double-blinded (participant and assessor), randomised controlled superiority trial with 1:1 random block allocation. Eligible participants have mild to moderate symptomatic knee OA and will be randomly assigned to receive either embolisation of aberrant knee neovasculature of genicular arterial branches or a placebo intervention. Outcome measures will be collected prior to the intervention and again 1, 6 and 12 months postintervention. The primary outcome is change in knee pain between baseline and 12 month assessment as measured by the Knee Injury and Osteoarthritis Outcome Score (KOOS). Secondary outcomes include change in self-reported physical function (KOOS), self-reported quality of life (KOOS, EuroQol: EQ-5D-5L), self-reported knee joint stiffness (KOOS), self-reported global change, 6 min walk test performance, and 30 s chair-stand test performance. Intention-to-treat analysis will be performed including all participants as randomised. To detect a mean between group difference in change pain of 20% at the one year reassessment with a two-sided significance level of \u03b1=0.05 and power of 80% using a two-sample t-test, we require 29 participants per arm which allows for 20% of participants to drop out.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Barwon Health Human Research Ethics Committee, 30 May 2016, (ref:15\/101). Study results will be disseminated via peer-reviewed publications and conference presentations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>Universal trial number U1111-1183-8503, Australian New Zealand Clinical Trials Registry, ACTRN12616001184460, approved 29 August 2016.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2016-014266","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:10:16Z","timestamp":1496103016000},"page":"e014266","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Protocol for a single-centre, parallel-arm, randomised controlled superiority trial evaluating the effects of transcatheter arterial embolisation of abnormal knee neovasculature on pain, function and quality of life in people with knee osteoarthritis"],"prefix":"10.1136","volume":"7","author":[{"given":"Steve","family":"Landers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Maister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Hely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"2024051612010021000_7.5.e014266.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60243-2"},{"key":"2024051612010021000_7.5.e014266.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204763"},{"key":"2024051612010021000_7.5.e014266.3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000161"},{"key":"2024051612010021000_7.5.e014266.4","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/lds038"},{"key":"2024051612010021000_7.5.e014266.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.08.010"},{"key":"2024051612010021000_7.5.e014266.6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00270-014-0944-8","article-title":"Transcatheter arterial embolization as a treatment for medial knee pain in patients with mild to moderate osteoarthritis","volume":"38","author":"Okuno","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024051612010021000_7.5.e014266.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.01.003"},{"key":"2024051612010021000_7.5.e014266.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.1.73"},{"key":"2024051612010021000_7.5.e014266.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01611.x"},{"key":"2024051612010021000_7.5.e014266.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.80"},{"key":"2024051612010021000_7.5.e014266.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.30422"},{"key":"2024051612010021000_7.5.e014266.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137844"},{"key":"2024051612010021000_7.5.e014266.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.05.017"},{"key":"2024051612010021000_7.5.e014266.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.063354"},{"key":"2024051612010021000_7.5.e014266.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.01.020"},{"key":"2024051612010021000_7.5.e014266.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.16.4.494"},{"key":"2024051612010021000_7.5.e014266.17","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20121217-14"},{"key":"2024051612010021000_7.5.e014266.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2024051612010021000_7.5.e014266.19","doi-asserted-by":"publisher","DOI":"10.2519\/jospt.1998.28.2.88"},{"key":"2024051612010021000_7.5.e014266.20","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2024051612010021000_7.5.e014266.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.4591"},{"key":"2024051612010021000_7.5.e014266.22","first-page":"783","article-title":"The six-minute walk test","volume":"48","author":"Enright","year":"2003","journal-title":"Respir Care"},{"key":"2024051612010021000_7.5.e014266.23","doi-asserted-by":"publisher","DOI":"10.2519\/jospt.2011.3515"},{"key":"2024051612010021000_7.5.e014266.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00009"},{"key":"2024051612010021000_7.5.e014266.25","unstructured":"KOOS FAQs. http:\/\/www.koos.nu\/. accessed 20 Dec 2016."},{"key":"2024051612010021000_7.5.e014266.26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150398"},{"key":"2024051612010021000_7.5.e014266.27","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s00296-012-2512-3","article-title":"The relationship between knee Injury and Osteoarthritis Outcome score (KOOS) and timed up and go test in patients with symptomatic knee osteoarthritis","volume":"33","author":"Sabirli","year":"2013","journal-title":"Rheumatol Int"},{"key":"2024051612010021000_7.5.e014266.28","unstructured":"The National Health and Medical Research Council, the Australian Research Council and the Australian Vice-Chancellors\u2019\u00a0Committee. National statement on ethical conduct in human research 2007. Canberra: BMJ Publishing Group, 2015."},{"key":"2024051612010021000_7.5.e014266.29","unstructured":"Australian New Zealand clinical trial registry (ANZCTR). http:\/\/www.anzctr.org.au\/."},{"key":"2024051612010021000_7.5.e014266.30","unstructured":"ICMJE. International Committee of Medical Journal Editors). recommendations for the Conduct, Reporting, Editing, and publication of Scholarly Work in Medical Journals . Updated 2016."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-014266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T19:20:59Z","timestamp":1715887259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-014266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,29]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/bmjopen-2016-014266"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-014266","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}